Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · Real-Time Price · USD
19.80
+0.23 (1.18%)
At close: Jul 10, 2026, 4:00 PM EDT
20.08
+0.28 (1.41%)
After-hours: Jul 10, 2026, 6:47 PM EDT
Greenwich LifeSciences Market Cap
Greenwich LifeSciences has a market cap or net worth of $290.63 million as of July 10, 2026. Its market cap has increased by 141.56% in one year.
Market Cap
290.63M
Enterprise Value
280.12M
1-Year Change
141.56%
Ranking
Category
Stock Price
$19.80
Market Cap Chart
Since the IPO on September 25, 2020, Greenwich LifeSciences's market cap has increased from $68.69M to $290.63M, an increase of 323.11%. That is a compound annual growth rate of 28.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 290.63M | -0.16% |
| Dec 31, 2025 | 291.08M | 97.19% |
| Dec 31, 2024 | 147.61M | 9.21% |
| Dec 29, 2023 | 135.16M | -30.79% |
| Dec 30, 2022 | 195.29M | -38.84% |
| Dec 31, 2021 | 319.29M | -31.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neumora Therapeutics | 311.28M |
| Bicycle Therapeutics | 307.87M |
| InflaRx | 301.95M |
| Indaptus Therapeutics | 297.83M |
| Eledon Pharmaceuticals | 297.61M |
| SAB Biotherapeutics | 292.09M |
| ALX Oncology Holdings | 285.95M |
| Turn Therapeutics | 281.20M |